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'is review compiled anthropometric data from 29 original articles, published between 1995 and 2015, corresponding to a total
sample of 6368 celiac disease subjects. Body mass index was the main parameter for measuring anthropometry (82.1%), followed
by body mass (78.6%), body fat (51.7%), bone mineral density and bone mineral content (46.4%), and fat-free mass (44.8%). 'e
main evaluation method was dual x-ray absorptiometry (83.3%), followed by bioimpedance (16.6%), skinfold thickness (16.6%),
and isotope dilution (5.5%). 'is compilation suggests that celiac disease patients without a gluten-free diet (WGFD) and celiac
disease patients with a gluten-free diet (GFD) show a lower body mass than the control group, with inconclusive data about
WGFD versus GFD. Body mass index is lower inWGFD and GFD compared to control group, and is lower inWGFD compared
to GFD. We observed lower values of FM and FFM in WGFD and GFD versus the control group. No difference was found
between WGFD versus GFD. BMD and BMC are lower in WGFD versus GFD and GFD versus the control group, with
inconclusive data about WGFD versus GFD. 'e findings of this review suggest that celiac disease patients must be periodically
evaluated through anthropometric parameters, since the pathology has the potential to modulate such values even in a gluten-
free diet, with these variables reflecting their healthy status. In parallel, the screening of different anthropometric assessment
methodologies can provide support for more accurate evaluations by scientists and clinical professionals who work with celiac
disease patients.
1. Introduction
1.1. Celiac Disease. Celiac disease is a chronic autoimmune
illness that manifests itself in individuals according to a
genetic predisposition with environmental interaction [1]. It
is characterized by an inflammatory condition as a conse-
quence of the body’s difficulty to process gluten proteins
from wheat, barley, and rye [2–4]. Epidemiological research
reveals a prevalence of 1 :100 (1%) in the United States
population, with a variation between 1 : 80 (1.25%) and 1 :
140 (0.71%) [3]. A previous review by Fasano et al. [5]
estimated that celiac disease is one of the most frequent
genetic disorders, affecting 0.5% to 1% of the world pop-
ulation. However, its diagnosis can be outdated, since its
clinical presentation overlaps with other more common
conditions.
Celiac disease manifests itself clinically in five ways: (1)
classic: small bowel mucosal malabsorption, chronic di-
arrhea, abdominal distension, abdominal pain, weight loss,
and flatulence; (2) atypical: the most common display of the
disease, in which there is an absence of or few gastrointestinal
symptoms, iron deficiency anemia, osteoporosis or osteo-
penia, infertility, and short stature; (3) silent: asymptomatic,
with a casual, histological, or serological diagnosis; (4) latent:
(A) individuals who are responsive to a gluten-free diet with a
normal histology and elevated intraepithelial lymphocytes;
(B) normal small bowel mucosa, without restriction to
gluten, with subsequent development of celiac disease; (5)
refractory: patients with celiac disease who do not respond to
a gluten-free diet [4].
Each manifestation has its own characteristics, from
gastrointestinal symptoms [6] to metabolic alterations [7, 8]
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and anthropometric changes, [9–11] mostly due to the
unsatisfactory absorption of nutrients as a consequence of
small bowel inflammation [6, 12]. 'e diagnosis of celiac
disease is based on clinical manifestations and serological
and histological laboratory tests from small bowel biopsies
[13]. It is accepted that serological markers from tissue
antitransglutaminase antibodies (TtG), immunoglobulin A
(IgA), and antiendomysium are sensitive and specific to the
initial celiac disease diagnosis [3, 14]. 'ere is good evidence
of a relationship between mucosal villi atrophies in the small
intestine and the histopathological characteristics of the
disease, and for this reason, a duodenal biopsy is recom-
mended for diagnosis confirmation [14]. 'e only treatment
for celiac disease is a gluten-free diet [2, 5], and patients with
good adherence to it may present anthropometric values
similar to healthy subjects [15]. However, other studies
suggest that, compared to the control group, celiac patients
with adherence to a gluten-free diet may still present de-
creased values in anthropometric parameters [9, 11, 16–18].
Considering the impact of celiac disease on metabolism
and body composition, we now proceed to review these
subjects and analyze data from experimental and epide-
miological research.
1.2. Metabolic and Anthropometric Alterations in Celiac
Disease Patients. 'e immunological process of celiac dis-
ease, triggered by gluten, leads to a chronic inflammatory
response, resulting in lesions associated with atrophy in the
small bowel mucosal villi [2], that results in unsatisfactory
nutrient absorption, including fatty acids, iron, transferrin,
glucose, electrolytes, vitamins, folic acid, and calcium
[17, 19, 20]. As a consequence, short stature, muscular fa-
tigue, iron deficiency anemia, hypovitaminosis (A, B12, D,
K), muscle fatigue [6, 9, 17], bone mineral content reduction
[10, 21], and osteoporosis, [22] among other intestinal
symptoms [6], may occur. Furthermore, celiac disease pa-
tients oxidize more carbohydrates as an energy source,
probably due to the insufficient absorption of nutrients by
the small bowel mucosa [9]. In Bode et al.’ study [16], celiac
disease patients with good adherence to gluten-free diet,
median age 42, compared to healthy subjects, had a lower
body mass index, a lower body fat percentage, and a lower
bone mineral content in the spine and forearms. Gonza´lez
et al. [17] analyzed women with celiac disease, between 20
and 60 years, with or without a gluten-free diet, and com-
pared them to a control group of women of the same age.
Women with celiac disease, in both groups, had a lower body
mass index and height compared to the control group, and
women with celiac disease without a gluten-free diet pre-
sented a lower body mass index than those on a gluten-free
diet, as well as a lower body fat and fat-free mass than the
control group. Capristo et al. [9], when analyzing adult
patients with celiac disease, with a mean age of
29.9± 7.6 years, found that those on a gluten-free diet
presented a lower body mass, fat, and fat-free mass than the
control group, with such parameters even lower in in-
dividuals without a gluten-free diet when compared to the
control group. 'e research of Bardella et al. [18], with 71
celiac disease individuals without a gluten-free diet, between
17 to 58 years, verified that height in men, body mass, and
bodymass index inmen and women were significantly lower
than the control group. Brambilla et al. [11] studied 150
celiac disease children without a gluten-free diet and found
lower values for body mass and body mass index when
compared to the control groups.
Celiac disease can be effectively treated through a gluten-
free diet [2, 5]. In the research by Barera et al. [23], in-
dividuals diagnosed with celiac disease revealed a lower body
mass, fat mass, fat-free mass, and bone mineral content
when compared to the control group, but after one year on a
gluten-free diet, anthoropometric values were similar to
healthy subjects. However, other evidence suggests that even
with a gluten-free diet, patients with celiac disease can
present lower anthropometric values, [9, 11, 16–18] in ad-
dition to nutritional deficiencies, such as lower levels of B6
and B12 vitamins, folic acid, iron, and transferrin [9, 24].
2. Methodology
For this review, original articles written in English were
selected through the Google Scholar search engine, using the
keywords: celiac disease, body composition, anthropometry,
anthropometric, body mass, body mass index, lean mass, fat
mass, fat-free mass, bone mineral content, and bone mineral
density. 'e articles were published between 1995 and 2015,
covering a period of 20 years.
'e inclusion criterion used was the presence of an-
thropometric data in celiac disease patients. 'e search
returned 29 original articles, corresponding to a total sample
of 6368 subjects with celiac disease. All data were included
for review and discussion.
Data were compiled according to evaluated anthropo-
metric parameters, the sex and age of the sample, and the
methodology undertaken. Data from the anthropometric
parameters were distributed in 3 groups: celiac disease
patients without a gluten-free diet (WGFD), celiac disease
patients with a gluten-free diet (GFD), and the control
group.
3. Results
3.1. Measured Parameters and Sample Characteristics. In the
reviewed studies, an analysis of body mass index (BMI) was
present in 82.1%, body mass (BM) in 78.6%, fat mass in
54.7%, fat-free mass in 44.8%, and bone mineral density
(BMD) and bone mineral content (BMC) in 46.4% of the
studies (Table 1).
Table 2 compiles the sample data of age and sex and the
presence of control groups in the reviewed studies. A
prevalence of adults, 3197, in relation to children and ad-
olescents, 443, was verified in the proportion of 7 :1, with
more female adult (52.9%) than male adult (47.1%) patients.
In children and adolescents, we are also found more females
(52.2%) than males (47.8%). In the control groups adults
were more prevalent, 70.5%, with children and adolescents
representing 29.5%.
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3.2. Anthropometric Measurement Methods. In order to
evaluate anthropometry, the studies used different meth-
odologies, including digital scales and weight balances for
body mass, wall, and infant stadiometers for height mea-
surement, plicometer, bioimpedance, isotope dilution, and
dual-energy x-ray absorptiometry (DXA) for fat mass and
fat-free mass, and DXA for measuring bone mineral density
and bone mineral content. 'e body mass index (BMI) was
mathematically defined by the weight/height ratio, with the
formula BMI�weight (kg)/height2 (m).
In Table 3, the frequency of different anthropometric
measurement methods is compiled. DXA is present in
83.3%, bioimpedance in 16.6%, skinfold thickness in 16.6%,
and isotope dilution in 5.5% of the studies. Moreover, the
most used DXA system was Lunar DPX, present in 9 studies,
followed by Lunar Prodigy and Hologic Delphy, present in 2
studies each, and Lunar DPA was used in 1 study.
3.3. Body Mass in Patients with Celiac Disease. 'e WGFD
group presented a lower BM when compared to the GFD
group, in 50% of the studies. 'is parameter was not dif-
ferent in the other 50% of studies. However, when compared
to the control group, WGFD presented a lower BM in 100%
of the reviewed studies. When GFD was compared to the
control group, 66% of the studies showed lower values, while
33.35% revealed no difference between these groups (Ta-
ble 4). Seven studies were not included in the BM table
because they did not discriminate between these data.
3.4. Body Mass Index in Patients with Celiac Disease.
When WGFD versus GFD and WGFD versus the control
group were compared, 71.4% of studies showed a lower BMI,
while 28.6% presented no difference between the groups.
However, GFD compared to the control group presented a
lower BMI in 60% of the studies, and no difference in 40% of
them (Table 5). Eight articles did not discriminate this
parameter between the groups and were not included in
Table 5. Passananti et al. compared WGFD to GFD in two
time periods, at two and five years, and found different
results, which were included separately in Table 5.
3.5. Fat Mass and Fat-Free Mass in Patients with Celiac
Disease. FM data are compiled in Table 6. When
Table 1: Anthropometric parameters measured in studies with
celiac patients.
Scientific publication BM BMI BMC BF FFMBMD
Bode et al. [25] X X X X
Bardella et al. [26] X X
Gonzalez et al. [27] X X X X X
Rea et al. [28] X X X X X
Mautalen et al. [29] X
Smecuol et al. [30] X X X X
Dickey and Bodkin [31] X X
De Lorenzo et al. [32] X X X X X
Bardella et al. [18] X X X X X
Barera et al. [23] X X X X X
Capristo et al. [9] X X X
Fabiani et al. [33]
Carbone et al. [10] X X X X
Zipser et al. [34] X
West et al. [35] X
Capristo et al. [36] X X X X
Dickey and Kearney [37] X X X
West et al. [38] X
Capristo et al. [20] X X X X
Cheng et al. [39] X X
Duerksen and Leslie [40] X X X X
Reilly et al. [41] X
Kabanni et al. [42] X
Passananti et al. [21] X X X
Brambilla et al. [11] X X
Valente [43] X X X X
Kurpaa et al. [44] X X X
Silva et al. [45] X X X X
Churruca et al. [46] X X X
Totais de um mesmo
paraˆmetro 78.6% 82.1% 46.4% 51.7% 44.8%
BM, Body mass; BMI, body mass index; BMD, bone mineral density; BMC,
bone mineral content; FM, fat mass; FFM, fat-free mass.
Table 2: Sample characteristics in studies with celiac patients.
Scientific publication
<18 years >18 years
Control
M F M F
Bode et al. [25] 7 15 No
Bardella et al. [26] 31 127 No
Gonzalez et al. [27] 32 85
Rea et al. [28] 8 15 No
Mautalen et al. [29] 5 9 No
Smecuol et al. [30] 1 24 No
Dickey and Bodkin [31] 35 15 No
Lorenzo et al. [32] 12 31 30
Bardella et al. [18] 14 15 8 15 52
Barera et al. [23] 20 51 142
Capristo et al. [9] 16 23 63
Fabiani et al. [33] 26 18 No
Carbone et al. [10] 15 33 41
Zipser et al. [34] 748 248 No
West et al. [35] 2649∗ 17925
Capristo et al. [36] 18 22
Dickey and Kearney [37] 114 257 No
West et al. [38] 57 30 No
Capristo et al. [20] 17 9 No
Cheng et al. [39] 248 121 No
Duerksen and Leslie [40] 6 37 233
Reilly et al. [41] 60 82 No
Kabanni et al. [42] 166 513 No
Passananti et al. [21] 95 No
Brambilla et al. [11] 103 47 288
Valente [43] 8 12 39
Kurpaa et al. [44] 40∗ No
Silva et al. [45] 23 8 31
Churruca et al. [46] 54 No
Totais 212 231 1513 1725 18975
'e data was separated in children and adolescents (<18 years) and adults
(>18 years), subdivided by sex, male (M) and female (F). Control: the
presence of a control groups. ∗Sex data not informed.'ese values were not
included in stratification by sex.
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compared to GFD and to the control group, 100% of the
studies presented a lower FM in the WGFD group.
When GFD was compared to the control group, 50% of
studies found no difference, 41.7% showed a lower FM,
and 8.3% a higher FM.
Table 7 presents the compiled FFM data. Compared to
GFD, WGFD showed a lower FFM in 66% of studies, and
Table 3: Anthropometric measurement methods in celiac patients
studies.
Scientific publication ST BIA DXA ID DXAdevices
Bode et al. [25] X X Lunar DPA
Gonzalez et al. [27] X Lunar DPX
Rea et al. [28] X X Lunar DPX
Smecuol et al. [30] X Lunar DPX
Lorenzo et al. [32] X X X Lunar DPX
Bardella et al. [18] X Hologic
Barera et al. [23] X Lunar DPX
Capristo et al. [9] X
Carbone et al. [10] X Lunar DPX
Capristo et al. [36] X Lunar DPX
Dickey and Kearney
[37] X Not shown
Capristo et al. [20] X Lunarprodigy
Duerksen and Leslie
[40] X Lunar DPX
Passananti et al. [21] X Hologic
Valente [43] X Lunar DPX
Kurpaa et al. [44] X Lunarprodigy
Silva et al. [45] X
Churruca et al. [46] X
Totais 16.6% 16.6% 83.3% 5.5%
ST, skinfold thickness; BIA, bioimpedance; DXA, dual-energy X-ray
absorptiometry; ID, isotope dilution.
Table 4: Body mass of celiac patients with and without gluten-free
diet.
Scientific
publication
WGFD
versus GFD
WGFD versus
control
GFD versus
control
Gonzalez et al.
[27] Lower Lower Lower
Rea et al. [28] Equal Lower Lower
Smecuol et al.
[30] Lower
Lorenzo et al.
[32] Equal
Bardella et al.
[18] Lower
Barera et al. [23] Lower Equal
Capristo et al. [9] Lower Lower Lower
Carbone et al.
[10] Lower Lower
Capristo et al.
[36] Equal Lower Lower
Capristo et al.
[20] Lower Lower
Duerksen and
Leslie [40] Lower
Brambilla et al.
[11] Lower
Valente [43] Equal
Kurpaa et al. [44] Equal
Silva et al. [45] Equal
Table 5: Body mass index of celiac patients with and without
gluten-free diet.
Scientific
publication
WGFD
versus GFD
WGFD versus
control
GFD versus
control
Bode et al. [25] Lower
Bardella et al.
[26] Lower Lower
Gonzalez et al.
[27] Lower Lower Lower
Rea et al. [28] Equal Equal
Bardella et al.
[18] Lower
Barera et al. [23] Equal Equal
Capristo et al.
[36] Lower Lower Lower
Capristo et al.
[20] Lower
Duerksen and
Leslie [40] Equal
Kabanni et al.
[42] Lower Lower
Passananti et al.
[21] Equal
Passananti et al.
[21] Lower
Brambilla et al.
[11] Lower
Valente [43] Equal
Kurpaa et al. [44] Equal
Silva et al. [45] Equal
Table 6: Fat mass of celiac patients with and without gluten-free
diet.
Scientific
publication
WGFD
versus GFD
WGFD versus
control
GFD versus
control
Bode et al. [25] Lower
Gonzalez et al.
[27] Lower Lower Lower
Rea et al. [28] Lower Equal
Smecuol et al.
[30] Lower Lower Equal
Lorenzo et al.
[32] Lower
Bardella et al.
[18] Lower Lower
Barera et al. [23] Lower Equal
Capristo et al. [9] Higher
Carbone et al.
[10] Lower
Capristo et al.
[36] Lower Equal
Capristo et al.
[20] Lower
Duerksen and
Leslie [40] Lower
Valente [43] Equal
Silva et al. [45] Equal
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there was no difference in 33.3% of them. However, WGFD
versus control subjects presented lower FFM values in 100%
of the studies. When compared to the control group, 36.4%
of studies showed a lower FFM in GFD, while 63.6% found
no difference.
Four articles, one for FM and three for FFM, did not
discriminate data relative to this parameter and were not
included in Tables 6 and 7.
3.6. Bone Mineral Density and Bone Mineral Content.
When WGFD was compared to the control group, it was
found to have a lower BMD and BMC in 90% of the studies.
In 66.5% of the studies, GFD presented a lower BMD and
BMC versus control patients, and there was no difference in
this comparison in 33.3% of the studies. 'ere were not
enough data to compare WGFD and GFD (Table 8) in
relation to BMD and BMC.
4. Discussion
'e anthropometric assessment is an important variable to
understand human metabolism in different health condi-
tions, [47, 48] including celiac disease. 'e data presented in
our sample of studies, there is a greater level of verification in
the body mass index (BMI) 82.1%, and body mass (BM)
78.6%. 'ese techniques are complementary, can be easily
accessed, and have a low cost. More complex and expensive
variables were used in smaller proportions in anthropo-
metric studies involving patients with celiac disease: fat mass
(FM) 53.6%, fat-free mass (FFM) 44.8%, bone mineral
density (BMD) 46.4%, and bone mineral content (BMC) 9%.
Despite the usefulness of BMI in the classification of sub-
jects, [49] other variables like fat mass, fat-free mass, bone
mineral density, and bone mineral content enable a more
comprehensive analysis of anthropometry. Future studies on
these topics needs to consider the complexity effects of celiac
disease in anthropometric parameters to provide for an
appropriate selection of assessment methods.
'e reviewed studies presented a higher proportion of
adult patients with celiac disease than children and ado-
lescents, being 7 :1, respectively, and a greater participation
of females (53.3%) than males (46.7%). A recent review of
ninety-six studies published between 1991 and 2016, in-
dicated a higher prevalence of celiac disease in females than
males (0.6% versus 0.4%) and in children than adults (0.9%
versus 0.5%). [50] Our data suggests that more research with
children and adolescents is necessary to establish a better
understanding of the anthropometric impacts as well as the
growth and development of celiac disease.
Regarding the anthropometry measurement methods, a
higher prevalence of DXA was observed, at 83.3% which,
despite its high cost, has the main advantage of simulta-
neously analyzing fat mass, fat-free mass, and bone mineral
content; moreover, it is considered the gold standard for
body composition measurements. [47, 48, 51, 52] In this
review, Lunar DPX was the most used DXA device, followed
by Lunar Prodigy, Hologic Delphy, and Lunar DPA. A
previous review from Marinangeli and Kassis [53] about
DXA comparative studies indicate that there are inter- and
intradevices differences, with under or overestimated values,
which may be explain by factors like beam type, gender
sample, and scan speed. However, quality-control procedures
may help the correct identification of changes in body
composition parameters [53].
Bioimpedance, with a frequency of 16.6%, depends on
many factors to obtain validity and precision, such as the
type of apparatus, researcher handling, room temperature,
Table 7: Free fat mass of celiac patients with and without gluten-
free diet.
Scientific
publication
WGFD versus
GFD
WGFD versus
control
GFD versus
control
Gonzalez et al.
[27] Lower Lower Lower
Rea et al. [28] Lower Equal
Smecuol et al.
[30] Lower Lower
Lorenzo et al.
[32] Lower
Bardella et al.
[18] Lower Lower
Barera et al.
[23] Lower Equal
Capristo et al.
[9] Equal Lower Lower
Carbone et al.
[10] Lower
Capristo et al.
[36] Equal Lower
Capristo et al.
[20] Lower
Valente [43] Equal
Silva et al. [45] Equal
Table 8: Bone mineral density and bone mineral content of celiac
patients with and without gluten-free diet results.
Scientific
publication
WGFD
versus GFD
WGFD versus
control
GFD versus
control
Bode et al. [25] Lower
Gonzalez et al.
[27] Lower Lower Lower
Mautalen et al.
[29] Lower Lower
Smecuol et al.
[30] Lower Lower
De Lorenzo et al.
[32] Lower
Bardella et al.
[18] Lower
Barera et al. [23] Lower Equal
Carbone et al.
[10] Lower Equal
Dickey and
Kearney [37] Lower
Duerksen and
Leslie [40] Lower Lower
Passananti et al.
[21] Lower Lower
Kurpaa et al. [44] Equal Equal
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and the preparation of subjects in relation to feeding, hy-
dration, physical exercise routine, and the consumption of
alcohol andmedicine [54].'ese limitations may explain the
lower utilization of bioimpedance in these studies. 'e
skinfold thickness evaluation is one of the most popular
research methods because of its low cost and simplicity, and
there is a good relation between subcutaneous fat and total
fat mass [47, 55]. However, its frequency of use in these
studies was low, a factor that can be explained by its limi-
tation to predict bone mineral density and bone mineral
content, being variables present in a larger proportion of the
reviewed studies. Isotope dilution was the least utilized
method, at 5.5%.'is method verifies the deuterium, oxygen
eighteen, and tritium concentration, thus determining the
total water, fat mass, and fat-free mass for the whole body
[56]. Despite having good precision, the technique is very
difficult to analyze, [47] being a possible cause for its re-
stricted use. We credit the greater preference for the DEXA
method among others to two factors: (1) the possibility of
accessing many variables simultaneously, allowing for more
complete and faster analyses; (2) the higher incidence of
bone mineral density and bone mineral content in the
reviewed methodologies, which are variables easily mea-
sured by DEXA devices.
Considering the lack of studies with two or more body
composition assessment methodologies, we cannot do a
comparative evaluation between them, since it is not possible
to claim that the result is a consequence of the selected
method or of group characteristics. However, previous re-
search suggests that skinfold thickness and bioimpedance
seems to provide underestimated results for body fat when
compared to DXA devices [57, 58].
Bodymass was evaluated in 80.7% of the reviewed studies.
All studies that evaluated body mass in WGFD patients and
most of the GFD studies revealed significantly lower levels of
this parameter when compared to the control group, cor-
roborating previous findings [9–11, 18, 23, 27, 28, 32, 36].
Although many publications present a gluten-free diet as a
bodymass promoter [11, 20, 23, 30, 40], our review found that
in half of the studies, there was no significant difference
between WGFD and GFD groups.
'e majority of the studies indicated that WGFD pre-
sented lower values of BMI than control subjects, in ac-
cordance with previous observations [27, 36, 40, 42, 59].
However, the majority of studies showed higher BMI values
in WGFD compared to GFD, suggesting that BMI seems to
be influenced by a gluten-free diet [11, 20, 21, 30, 41].
However, most studies also demonstrated that WGFD have
lower values of BMI when compared to the control group,
suggesting that the gluten-free diet may not be able to
normalize this parameter [11, 16, 32, 39]. In the work ofWest
et al. [35], which proposed a categorization of samples
thorough BMI, a greater prevalence of WGFDs in the un-
derweight classification was verified. In addition, Kabbani
et al. [42] observed a significant probability of WGFD and
GFD patients to be in the underweight classification in re-
lation to the overweight and obesity classifications.
'emensuration of fat mass and fat-free mass in patients
with celiac disease constitutes an important parameter to
investigate the effects of this disease on anthropometric and
metabolic functioning. Moreover, the increased body mass
found in GFD subjects seems to be essentially related to an
increase in fat mass [9, 20, 30, 36]. 'e studies compiled
indicated lower values of FM in WGFD compared to GFD
and the control group, corroborating with previous publi-
cations [9, 10, 16, 18, 23, 27, 28, 30, 32, 36, 40]. Although
all the publications revealed a rise of FM in GFD pa-
tients, only half of these studies showed the same values
when GFD patients are compared to the control group
[23, 28, 30, 36, 43, 60].
In the majority of publications, GFD presented lower
values of FFM than the control group, suggesting that a
gluten-free diet may not be able to normalize FFM values in
relation to healthy people [9, 10, 17, 18, 30, 32, 36].
'e analysis of bone mineral density and bone mineral
content revealed that the majority of publications found
significantly lower levels of these variables in WGFD than in
control groups [10, 17, 18, 21, 23, 29, 30, 32, 37, 40, 44]. A few
publications suggest that a gluten-free diet significantly
promotes bone mineral density and bone mineral content
[21, 29, 30] with some articles indicating that celiac disease
patients submitted to a one year gluten-free diet can present
normal values of these parameters [10, 23, 44]. However,
most of the reviewed studies showed lower mineral density
and bone mineral content values in GFD patients compared
to control groups [17, 21, 25, 29, 30, 40, 44].
Our limitations are similar to those observed by Bardella
et al., which includes the difficulty in comparing previously
published anthropometry and nutritional data in patients
with celiac disease. Data ambiguity and the dependence on
other variables such as age at diagnosis, symptom duration
before diagnosis, and the presence or absence of un-
satisfactory nutrient absorption constitutes important fac-
tors of interference.
5. Conclusion
Celiac disease significantly changes anthropometric pa-
rameters, which can be improved by a gluten-free diet.
Despite this, celiac disease patients may not improve an-
thropometric variables to values similar in healthy people.
'is review demonstrated that WGFD compared to the
control group showed lower values in all anthropometric
variables. GFD compared to WGFD presented higher values
in BMI, FM, and FFM, and there was inconclusive data
about BM, BMD, and BMC. GFD patients did not present
different FFM values from control.
Anthropometric parameters that were more utilized
included body mass index and body mass, followed by fat
mass, bone mineral density and bone mineral content, and
fat-free mass, which were most measured by dual-energy
x-ray absorptiometry (DXA), followed by bioimpedance,
skinfold thickness, and isotope dilution.
'e findings of this review suggest that celiac disease
patients must be periodically evaluated through anthropo-
metric parameters, since the pathology has the potential to
modulate such values even in a gluten-free diet, with these
variables reflecting their healthy status. In parallel, the
6 Journal of Nutrition and Metabolism
screening of different anthropometric assessment method-
ologies can provide support for more accurate evaluations by
scientists and clinical professionals who work with celiac
disease patients.
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